The Role of Administration of IV IntraLipid in Level Of Consciousness in coma Poisoned Patients

The Role of Administration of IV IntraLipid in Level Of Consciousness in coma Poisoned Patients Referred to Emergency Service of Yaft Abad Hospital during october 2010 to March 2011

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201010134925N1

Enrollment

100

Registered

2010-11-12

Start date

2010-10-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

drug poisoning. Injury, poisoning and certain other consequences of external causes

Interventions

Intervention 1: administration a bolus of 20cc/kg of 10% intralipid. Intervention 2: Control group: no intervention.

Treatment - Drugs

administration a bolus of 20cc/kg of 10% intralipid

Control group: no intervention

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: GCS less than 8 Exclusion criteria: Presence of specific antidote (such as naloxone)

Exclusion criteria

Exclusion criteria:

Design outcomes

Secondary

Measure	Time frame
ABG. Timepoint: Before Intralipid prescription and 30 minutes after drug usage. Method of measurement: Answer assessment test using a special device to measure ABG.;BS(blood sugar). Timepoint: Before Intralipid prescription and 6 hours after drug usage. Method of measurement: Assessment of blood biochemistry test answers using a special device to measure blood biochemistry.;BP(blood pressure). Timepoint: Before Intralipid prescription and 30 minutes after drug usage. Method of measurement: by trained person by use of Sphygmomanometer.;EKG. Timepoint: Before Intralipid prescription and 30 minutes after drug usage. Method of measurement: by trained person by use of electerocadiogeraph device and reading ECG.;Blood NA. Timepoint: Before Intralipid prescription and 6 hours after drug usage. Method of measurement: Assessment of blood biochemistry test answers using a special device to measure blood biochemistry.;RR(respiratory rate). Timepoint: Before Intralipid prescription and 30 minutes after drug usage. Method of measurement: By trained person by manually counting and simultaneously by monitoring devices to ensure.;PR(pulse rate). Timepoint: Before Intralipid prescription and 30 minutes after drug usage. Method of measurement: By trained person by manually counting and simultaneously by monitoring devices to ensure.;T(temperature). Timepoint: Before Intralipid prescription and 30 minutes after drug usage. Method of measurement: By trained person using medical mercury thermometer.;Blood K. Timepoint: Before Intralipid prescription and 6 hours after drug usage. Method of measurement: Assessment of blood biochemistry test answers using a special device to measure blood biochemistry.;Blood Urea. Timepoint: Before Intralipid prescription and 6 hours after drug usage. Method of measurement: Assessment of blood biochemistry test answers using a special device to measure blood biochemistry.;Blood Cr. Timepoint: Before Intralipid prescription and 6 hours after drug usage. Met	—

Measure

Time frame

ABG. Timepoint: Before Intralipid prescription and 30 minutes after drug usage. Method of measurement: Answer assessment test using a special device to measure ABG.;BS(blood sugar). Timepoint: Before Intralipid prescription and 6 hours after drug usage. Method of measurement: Assessment of blood biochemistry test answers using a special device to measure blood biochemistry.;BP(blood pressure). Timepoint: Before Intralipid prescription and 30 minutes after drug usage. Method of measurement: by trained person by use of Sphygmomanometer.;EKG. Timepoint: Before Intralipid prescription and 30 minutes after drug usage. Method of measurement: by trained person by use of electerocadiogeraph device and reading ECG.;Blood NA. Timepoint: Before Intralipid prescription and 6 hours after drug usage. Method of measurement: Assessment of blood biochemistry test answers using a special device to measure blood biochemistry.;RR(respiratory rate). Timepoint: Before Intralipid prescription and 30 minutes after drug usage. Method of measurement: By trained person by manually counting and simultaneously by monitoring devices to ensure.;PR(pulse rate). Timepoint: Before Intralipid prescription and 30 minutes after drug usage. Method of measurement: By trained person by manually counting and simultaneously by monitoring devices to ensure.;T(temperature). Timepoint: Before Intralipid prescription and 30 minutes after drug usage. Method of measurement: By trained person using medical mercury thermometer.;Blood K. Timepoint: Before Intralipid prescription and 6 hours after drug usage. Method of measurement: Assessment of blood biochemistry test answers using a special device to measure blood biochemistry.;Blood Urea. Timepoint: Before Intralipid prescription and 6 hours after drug usage. Method of measurement: Assessment of blood biochemistry test answers using a special device to measure blood biochemistry.;Blood Cr. Timepoint: Before Intralipid prescription and 6 hours after drug usage. Met

—

Primary

Measure	Time frame
GCS. Timepoint: Before Intralipid prescription and 30 minutes after drug usage. Method of measurement: Based on physical examination by a trained person and based on the specific scoring method for this criteria(up to six for movement response, five for language response, four for the eye response).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBahareh Sepehrian, MD

Iran University of Medical Sciences and health services

b.sepehrian@stu.iums.ac.ir+98 912 719 6646

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026